Sun Pharma sues Zydus Cadila for trademark violation

24445 Investors following Sun Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Sun Pharma sues Zydus Cadila for trademark violation

There's a new pharma battle brewing. Sun Pharma citing trademark violations by Zydus Cadila has got an ex parte injunction from the Madras High Court against the sale of Zydus Cadila's anti-depressant drug Veniz, reports CNBC-TV18's Divya Rajagopal.

Post your opinion here

 

0

Tweet

Share on Tumblr

There's a new pharma battle brewing. Sun Pharma citing trademark violations by Zydus Cadila has got an ex parte injunction from the Madras High Court against the sale of Zydus Cadila's anti-depressant drug Venz, reports CNBC-TV18's Divya Rajagopal.
Here is a verbatim transcript of Divya Rajagopal's comments on CNBC-TV18. Also watch the accompanying video. 
Sun Pharmaceutical's has dragged Zydus Cadila for trademark violation of Sun Pharma's anti-depressant named Veniz. Zydus Cadila has launched a similar anti-depressant drug by the name of Venz. The Madras High Court has ordered an ex parte interim injunction against Zydus Cadila and has ordered that Zydus Cadila cannot sell its anti-depressant drug Venz till the time it is sorted out.
Sun Pharma has been selling Veniz over the last 10 years and is one of the major contributors for Sun Pharma's business. The next hearing will take place some time during the next week.